1. Home
  2. OVID vs BBNX Comparison

OVID vs BBNX Comparison

Compare OVID & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$2.64

Market Cap

522.6M

Sector

Health Care

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$16.35

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVID
BBNX
Founded
2014
2015
Country
United States
United States
Employees
N/A
423
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
522.6M
493.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
OVID
BBNX
Price
$2.64
$16.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$4.60
$23.80
AVG Volume (30 Days)
1.5M
1.3M
Earning Date
05-13-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
3.90
N/A
EPS
N/A
N/A
Revenue
$7,252,000.00
N/A
Revenue This Year
N/A
$34.90
Revenue Next Year
$19.34
$34.63
P/E Ratio
N/A
N/A
Revenue Growth
1181.27
N/A
52 Week Low
$0.52
$8.80
52 Week High
$3.11
$32.71

Technical Indicators

Market Signals
Indicator
OVID
BBNX
Relative Strength Index (RSI) 59.56 42.57
Support Level $2.56 $12.87
Resistance Level $2.77 $15.26
Average True Range (ATR) 0.15 1.19
MACD 0.03 -0.36
Stochastic Oscillator 92.78 25.23

Price Performance

Historical Comparison
OVID
BBNX

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: